- Tuesday, November 4, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Competent Cells Market By Type (Chemically Competent Cells and Electrocompetent Cells), By Application (Cloning, Protein Expression and Other Applications), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa)-Global Forecast to 2027.
Description
Global Competent Cells Market Overview:
Capable cells are routinely adopted in molecular cloning to propagate and maintain cloned DNA in plasmids. Competent cells are E. coli cells that have been specially treated to transform efficiently. These cells have a much higher capacity for binding DNA to the cell surfaces than non-competent cells. Competent cells have altered cell walls that allow the DNA to easily pass through them. Some cells need to be shown up to some electrical or chemical treatments to make them competent. Treatment with calcium ions is the standard method for the preparation of these cells.Global Competent Cells Market Insights
The global competent cells market size was valued at USD 1.47 billion in 2019 and projected to reach USD 2.96 billion by 2027, growing at a CAGR of 9.8% during the forecast period, 2020-2027. The significant factors are the growing demand for molecular cloned products and recombinant proteins. Additionally, the advancement in molecular cloning research will spur the global competent cells industry in the future periods. Furthermore, the growing public-private funding for competence activities and rising adaptation by the pharmaceutical industries are expected to witness the remarkable growth of competent cells. The increasing demand for retrovirus vaccines &therapies and rising R&D investments are expected to propel the demand for capable cells over the coming years. Moreover, growing research in therapeutics and increasing development on therapeutic products in treating various diseases and favorable reimbursement positively impact the market for competent cells in the healthcare industry. Furthermore, the rapid expansion in customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing awareness of biomedical applications are fueling the demand for a competent cells market. The growing demand for products from recombinant DNA technology and technological advancements in molecular engineering will bolster the growth of capable global cells market share. Additionally, the ever-increasing pharmaceutical industry research and increasing healthcare demands in the developing world propelling the growth of the competent cells market across the globe.Growth Driver
Competent cells are used in molecular cloning to propagate and maintain cloned DNA in plasmids. These cells are used for routine cloning and sub-cloning, and protein expression. Due to the advantages of large market size, low market concentration, and gradual advances in applications, competent cells have attracted various enterprises to the layout. However, restrictions are often challenging to achieve. Also, the high cost of research & competent cells kits and entry barriers due to market consolidations are likely to prevent the growth of the competent cells market.Type Segmental Analysis
The global competent cells market is segregated into chemically competent cells and electrocompetent cells based on the type. The chemically competent cells segment is estimated to witness the highest growth over the analysis timeframe due to high adaptation in cloning and sub-cloning application. The electrocompetent cells will grow significantly due to their ability to offer high transformation efficiencies and high adoption in molecular biology applications such as the generation of cDNA libraries or constructing gene banks.Application Segmental Analysis
Based on the application, the global competent cells market is classified into cloning, protein expression, and other applications. The cloning application is further segmented into sub-cloning & routine cloning, phage display library construction, toxic/unstable DNA cloning, high-throughput cloning, and other applications further divided into mutagenesis and single-stranded DNA production lentiviral vector production, and enormous plasmid transformation. The cloning applications are expected to be the highest revenue share for competent cells during the forecast period. The segment’s growth is generally attributed to the rising research on cloning and rising government support and funding. The other applications will witness a lucrative growth rate in the estimated period due to technological advancements in competent cells, the rising intensity of research, and rising research in mutagenesis.End-User Segmental Analysis
Based on the end-user, the global competent cells market is segmented into pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations. The pharmaceuticals and biotechnology companies segment will dominate the global competent cells market by 2027. Due to the rise in the number of biopharmaceutical industries using competent cells, rising investment for developing proteomics & genomic-based research products, and increasing demand for novel drugs. The academic research institutes accounted for the largest share of the competent cells market in 2019 because of the increasing use of competent cells for research purposes, economic expansion, and government focus on broader healthcare policies.Region Segmental Analysis
The global competent cells market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to have significant growth over 2020-2026. It is due to increasing R&D activities, leading industry players offering innovative products, and increasing healthcare expenditure. The Asia Pacific will generate a prominent share of the competent cells market by 2027. Due to the increasing research in molecular engineering, we are continually improving healthcare infrastructure in the region and mounting health care expenditures in growing countries such as India and China.Competitor Analysis
Companies such as Merck KGaA, Promega Corporation, Takara Bio, Agilent Technologies, New England Biolabs, QIAGEN N.V., Illumina, Bio-Rad Laboratories, GeneScript Corporation, OriGene Technologies, Beijing TransGen Biotech Co Ltd, and Life Technologies Pvt. Ltd is the key player in the global competent cells market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global competent cells kits manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to competent cells
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling commences with identifying a target market where historical data exists. A Market may include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Type- Chemically Competent Cells
- Electrocompetent Cells
- Cloning
- Protein Expression
- Other Applications
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
DNA Damage Response Drugs Market
Virtualization Software Market
General Anesthesia Drugs Market
Global Cleanroom Technologies Market
Table Of Contents
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Competent Cells Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Type
- Market Size & Forecast,2016-2027
- North America Competent Cells Market Overview
- North America Competent Cells Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America Competent Cells Market Share & Forecast,2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Competent Cells Market
- By Type
- North America Competent Cells Market Size & Forecast, 2016-2027
- Europe Competent Cells Market Overview
- Europe Competent Cells Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe Competent Cells Market Share & Forecast,2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Competent Cells Market
- By Type
- Europe Competent Cells Market Size & Forecast, 2016-2027
- Asia Pacific Competent Cells Market Overview
- Asia Pacific Competent Cells Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific Competent Cells Market Share & Forecast, 2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Competent Cells Market
- By Type
- Asia Pacific Competent Cells Market Size & Forecast, 2016-2027
- South America Competent Cells Market Overview
- South America Competent Cells Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America Competent Cells Market Share & Forecast,2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Competent Cells Market
- By Type
- South America Competent Cells Market Size & Forecast, 2016-2027
- Middle East & Africa Competent Cells Market Overview
- Middle East & Africa Competent Cells Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Middle East & Competent Cells Market Share & Forecast, 2016-2027
- By Type
- Chemically Competent Cells
- Electrocompetent Cells
- By Application
- Cloning
- Protein Expression
- Other Applications
- By End-User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Competent Cells Market
- By Type
- Middle East & Africa Competent Cells Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Promega Corporation
- Takara Bio
- Agilent Technologies
- New England Biolabs
- QIAGEN N.V.
- Illumina
- Bio-Rad Laboratories
- GeneScript Corporation
- OriGene Technologies
- Beijing TransGen Biotech Co Ltd
- Life Technologies Pvt. Ltd
Methodology
Request Sample
